Literature DB >> 10503915

Causes of excess mortality in cerebral palsy.

D Strauss1, W Cable, R Shavelle.   

Abstract

It is well known that individuals with cerebral palsy (CP) are subject to higher mortality than the general population but the causes of this have not been systematically analysed. This study investigates mortality in a Californian population of 45,292 individuals with CP, 4028 of whom died during the 1986 to 1995 study period. The aims of this study were to identify diseases that may be causally linked with CP, and diseases whose diagnosis and/or treatment need improvement. Overall, the standardized mortality ratio (SMR) was 8.4. Mortality from breast cancer was three times that of the general population, suggesting poorer detection and/or treatment. The dramatic elevation of mortality due to brain cancer, especially in children (SMR=24), raises the possibility of a link between this and CP. Cause of death was non-specific in some individuals. Therefore, these SMRs are conservative. As expected, SMRs due to respiratory diseases were very high but, contrary to anecdotal reports, such diseases did not account for most deaths. High SMRs were also found for diseases of the circulatory and digestive systems. Finally, a marked elevation of deaths was due to external causes, including drowning and being hit by motor vehicles.

Entities:  

Mesh:

Year:  1999        PMID: 10503915     DOI: 10.1017/s001216229900122x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  39 in total

Review 1.  The cerebral palsies: a physiological approach.

Authors:  Jean-Pierre Lin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-03       Impact factor: 10.154

2.  Implications of mobility impairment on the diagnosis and treatment of breast cancer.

Authors:  Lisa I Iezzoni; Elyse R Park; Kerry L Kilbridge
Journal:  J Womens Health (Larchmt)       Date:  2010-10-30       Impact factor: 2.681

3.  Age-related trends in cardiometabolic disease among adults with cerebral palsy.

Authors:  Mark D Peterson; Neil Kamdar; Edward A Hurvitz
Journal:  Dev Med Child Neurol       Date:  2018-04-27       Impact factor: 5.449

4.  Cortical bone deficit and fat infiltration of bone marrow and skeletal muscle in ambulatory children with mild spastic cerebral palsy.

Authors:  Daniel G Whitney; Harshvardhan Singh; Freeman Miller; Mary F Barbe; Jill M Slade; Ryan T Pohlig; Christopher M Modlesky
Journal:  Bone       Date:  2016-10-11       Impact factor: 4.398

5.  Multimorbidity in Middle-Aged Adults with Cerebral Palsy.

Authors:  Nicole Cremer; Edward A Hurvitz; Mark D Peterson
Journal:  Am J Med       Date:  2017-01-05       Impact factor: 4.965

6.  Comparison of the ratio of upper to lower chest wall in children with spastic quadriplegic cerebral palsy and normally developed children.

Authors:  Eun Sook Park; Jung Hyun Park; Dong-Wook Rha; Chang Il Park; Chan Woo Park
Journal:  Yonsei Med J       Date:  2006-04-30       Impact factor: 2.759

7.  Greater Visceral Fat but No Difference in Measures of Total Body Fat in Ambulatory Children With Spastic Cerebral Palsy Compared to Typically Developing Children.

Authors:  Daniel G Whitney; Harshvardhan Singh; Chuan Zhang; Freeman Miller; Christopher M Modlesky
Journal:  J Clin Densitom       Date:  2018-09-22       Impact factor: 2.617

8.  Death within 8 years after childhood convulsive status epilepticus: a population-based study.

Authors:  Suresh S Pujar; Brian G R Neville; Rod C Scott; Richard F M Chin
Journal:  Brain       Date:  2011-09-13       Impact factor: 13.501

9.  Acute functional deterioration in a child with cerebral palsy.

Authors:  Elizabeth Smyth; Chandrasekaran Kaliaperumal; Jane Leonard; John Caird
Journal:  BMJ Case Rep       Date:  2012-12-18

Review 10.  Secondary muscle pathology and metabolic dysregulation in adults with cerebral palsy.

Authors:  Mark D Peterson; Paul M Gordon; Edward A Hurvitz; Charles F Burant
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-08-21       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.